Spike Babaian, MA, is a former adjunct professor from New York City, using e-cigarettes since 2008. She founded the first consumer group for vapers, in 2009. She co-authored the first peer reviewed paper in the US on vapor toxicity. In 2011, she opened VapeNY, a vape shop which has grown to 4 locations. She has day to day contact with tens of thousands of vapers. She has consulted with hundreds of politicians, researchers, media outlets and government bodies regarding e-cigarettes for more than 10 years to educate academia, scientists and the public on vapor product use and safety.
Terry Barnes is an Australian policy analyst, political commentator and currently Fellow of the UK Institute of Economic Affairs. He has written and spoken extensively on excessive health regulation in Australia, especially in relation to Tobacco Harm Reduction. He also advises THR advocates working to ensure the regulatory environment accepts and not rejects disruptive innovations including vaping.
Clive Bates has had a diverse career in the public, private and not-for-profit sectors. Starting out with IBM, he then switched career to work in the environment movement. From 1997-2003 he was Director of Action on Smoking and Health (UK), campaigning to reduce the harms caused by tobacco. In 2003 he joined Prime Minister Tony Blair’s Strategy Unit as a civil servant and worked in senior roles in the public sector and for the United Nations in Sudan. He is now Director of The Counterfactual, a consulting and advocacy practice focussed on a pragmatic approach to sustainability and public health.
Samrat Chowdhery leads consumer advocacy in India with a focus on tobacco harm reduction for users of both combustible and dangerous smokeless tobacco products. A former journalist, Mr Chowdhery is the founder-director of Association of Vapers India, and Secretary/Treasurer of the International Network of Nicotine Consumer Organisations. He was honoured with the ‘Advocate of the Year’ award at the Global Forum for Nicotine held in Warsaw in June 2018. Mr Chowdhery is currently working on a project that evaluates the efficacy and affordability of lower-risk alternatives for bidi smokers and khaini/gutka users.
Gregory Conley is the president of the American Vaping Association, a nonprofit organization that champions regulatory policies toward vapor products designed to maximize the effectiveness of vaping for quitting smoking. He is one of the most prominent defenders of vaping in the United States and has appeared on CNN, Fox News, and MSNBC. Mr Conley is also an attorney and a consultant on vaping legislative and regulatory issues. He began working on vaping issues in 2010 after quitting smoking with a vapor product while in law school. He served as the pro bono legislative director for the Consumer Advocates for Smoke-Free Alternatives Association from 2011 to 2014.
Dr Sharon Cox has over ten years’ experience working in the drug and alcohol field, including working at front-line services with some of the UK’s most deprived communities. She has a special interest in harm reduction and the use of translational methodologies in vulnerable and marginalised groups. She currently works as a Trial Manager at London South Bank University’s Centre for Addictive Behaviours Research. Her current research is focused on e-cigarette puffing patterns associated with high and low nicotine e-liquid strength, smoking and alcohol consumption within disadvantaged groups and the impact of health warning labels on reduced risk products.
Abrie du Plessis taught Law at the University of Stellenbosch, South Africa, before he joined a multinational company as an intellectual property practitioner. As part of several subsequent roles within the Tobacco Industry he spent more than a decade tracking the development of the WHO Framework Convention on Tobacco Control (FCTC). While based in Brussels he also followed the initial development of the 2014 Tobacco Products Directive. After retiring in 2013 he joined the South African Trade Law Centre (Tralac) as an Associate. He still follows FCTC developments and takes a special interest in the approach of the Convention towards novel and emerging nicotine products, most of which did not exist when its final text was agreed.
Konstantinos E. Farsalinos, M.D., is a research fellow at the Onassis Cardiac Surgery Center in Athens-Greece, at the Department of Pharmacy, University of Patras-Greece and at the National School of Public Health-Greece. He has been conducting laboratory and clinical research on e-cigarettes as a principal investigator since 2011. Examples of his work include the first study on the cytotoxic effects of e-cigarette vapor on cultured cells and the immediate effects of e-cigarette use on cardiac function and coronary circulation. As of late 2019, he has published more than 80 studies and articles in international peer-reviewed scientific journals about tobacco harm reduction. He has been recognized as one of the world's most influential researchers of the past decade by Web of Science, receiving the Highly Cited Researcher 2019 recognition.
Dr Marina Foltea is founder and Managing Director at Trade Pacts, a trade and investment consultancy based in Geneva advising global companies and governmental institutions. Her main areas of expertise are international trade agreements and economic organisations, as well as public policy and affairs. She takes keen interest in the regulations and policy applicable to fast-moving consumer goods, in particular tobacco and e-cigarettes.
Dr. Moira Gilchrist was appointed Vice President Reduced Risk Products Corporate Affairs in January 2017. Prior to this she was based in our R&D function where she was Director of Scientific Engagement from 2014 to 2016. Since joining PMI in 2006, Dr. Gilchrist has worked exclusively on our Reduced-Risk Product program in roles related to Research and Development as well as Commercialization. Prior to joining PMI, Dr. Gilchrist worked in the pharmaceutical sector for more than 10 years. She was a Principal Consultant in PwC and IBM’s pharmaceutical industry consulting groups and prior to that held positions in both industry and charity sectors developing new drug formulations. Dr. Gilchrist holds a degree in Pharmacy and a PhD. in Pharmaceutical Sciences, both from the University of Strathclyde in Glasgow, Scotland.
Marewa Glover is Director of the independent Centre of Research Excellence: Indigenous Sovereignty & Smoking based in Auckland, New Zealand but focused on tobacco use among all indigenous people globally. She is also Tobacco Section Editor for the international Harm Reduction Journal. She has led and collaborated on many studies resulting in over 100 scientific publications. Her dedication to reducing tobacco smoking harm over 25 years and advocating for a harm reduction approach to smoking was recognized with several awards. Marewa was appointed as an INNCO scientific advisor and is an associate member of the NNA UK. Marewa is a former Massey University Professor of Public Health and former Chair of End Smoking NZ.
Will Godfrey is the founding editor-in-chief of Filter (https://filtermag.org), an online magazine that launched in 2018 to cover drug use, drug policy and human rights through a harm reduction lens. He's also the executive director of The Influence Foundation, the nonprofit behind Filter. He previously founded The Influence, an award-winning drug policy news site, and ran Substance.com and the addiction-focused site The Fix. Before that, he co-founded an award-winning print publication for incarcerated people in London. He has consulted for numerous organisations in the drug policy and harm reduction space. He lives in New York.
A global legal and compliance nicotine, cannabis and CBD expert, and currently an independent consultant/principal at RegulationStrategy.com, Patricia Kovacevic’s experience comprises past General Counsel and Chief Compliance Officer roles at a leading nicotine/CBD multinational, and senior legal and regulatory positions at, among others, Philip Morris International and Lorillard. While at Lorillard, her team obtained the first ever premarket authorization for a tobacco product issued by the FDA under the Tobacco Control Act (2013). At Nicopure Labs she spearheaded the litigation against the FDA challenging the so-called “deeming rule”. Prior to joining Lorillard she was a partner at Patton Boggs. Her expertise includes global e-cigarette and tobacco regulation, cannabis regulation, compliance and all regulatory aspects of marketing/media communications,
As Head of Tobacco Research at Euromonitor, Shane MacGuill conducts in-depth research and provides strategic analysis on tobacco and nicotine globally. He works with a range of industry stakeholders to map the future evolution of these industries and their relationship to cannabis. Shane is a frequent contributor for media outlets on related topics, including: CNBC, Reuters, France 24, BBC, The Economist, Bloomberg, Financial Times, New York Times and Times of London. In addition to contributing to key industry and retail conferences, Shane engages in research forums and special projects with clients on topics such as regulation, reduced risk products and future industry trends.
David MacKintosh is the Head of Community Safety for the City of London, and has also been the Policy Adviser/Director to the London Drug and Alcohol Policy Forum (LDAPF) since 2001. He has been involved in a number of innovative campaigns around issues including drug driving, substance misuse in the workplace and improving awareness around drug safety in clubs and pubs. The LDAPF is funded by the City of London as part of its commitment to improving the life of all those who live and work in London. For the last eight years he has also been seconded to the Greater London Authority to provide advice around substance use issues and health inequalities.
Dr. Pini Matzner is a Senior Data Analyst and Data Team Lead at Signals-Analytics, a next-generation advanced analytics company that specializes in incorporating vast number and types of data sources and uncover powerful trends along with generating predictive analytics. He is also an experienced researcher and lecturer in the fields of Neuroscience and Psychoneuroimmunology, with a vast understanding of pre-clinical and clinical research, and over 20 published articles and studies in peer-reviewed scientific journals.
Kevin McGirr, Clinical Professor at the University of California San Francisco School of Nursing; has taught in schools of medicine, social work and public health and was a Nehru-Fulbright Scholar in Pondicherry India, 2013-2014. He has extensive experience in providing and managing behavioral health services in Boston, San Francisco and New York. He holds masters degrees in public health, psychiatric nursing and an all but dissertation doctorate in public health. He has an interest in the utilization of harm reduction in substance use services and in particular utilizing Harm Reduction Tobacco interventions for persons with serious mental illness.
Michael McGrady is an accomplished independent public policy researcher and journalist based in Colorado, United States of America. He has an educational background in global politics from the University of Colorado, Colorado Springs. He is one of the youngest people ever to be featured in the editorial pages of The Wall Street Journal and The South China Morning Post. Other outlets that have published or cited his work include The Jerusalem Post, New York Post, The Spectator (U.K.), Spiked (U.K.), the Denver Post, the Washington Examiner, The Hill, and many others internationally. Currently, McGrady’s research and journalism has focused on the intersections of tobacco harm reduction and economics.
Ethan Nadelmann has played a leading role in harm reduction and other drug policy reform efforts in the United States and globally since the late 1980s. He was born in New York City, received his BA, JD, and PhD from Harvard, and taught politics and public affairs at Princeton University (1987-1994). He then founded first The Lindesmith Center (1994-2000, a drug policy institute created with the philanthropic support of George Soros) and then the Drug Policy Alliance (DPA), which he directed from 2000 until 2017. His TED Talk, “Why we need to end the drug war,” has over two million views.
Chimwemwe Ngoma is a social scientist, tobacco harm reduction advocate and Project Manager for THR Malawi which is an information dissemination project on Tobacco Harm Reduction and Nicotine science in Malawi. Chimwemwe has worked as a Content Writer Consultant at Solimar International, he has also worked as a Project Officer at Drug Fight Malawi.
Dr Notley is a Senior Lecturer in Mental Health at the Norwich Medical School, University of East Anglia, and lead of the Addictions Research Group. She is a social scientist with extensive experience in all aspects of addiction research. Her current programme of research is focused on tobacco smoking relapse prevention, particularly working with vulnerable groups. Dr Notley’s research interests in alternative nicotine delivery devices primarily explores social and culturally pertinent aspects of vaping. Her work emphasises the public health potential of vaping for smoking relapse prevention, taking a ‘real world’ approach to highlight the importance of user focused perspectives on switching from traditional smoking to vaping.
Dr. John Oyston is a medical doctor specializing in anesthesiology. Since 2006 he has been involved in numerous tobacco control issues including “Stop Smoking for Safer Surgery”, the “Campaign for the Quit Quarter”, “Tobacco21.ca”, and, most recently “Quit by Vaping”. He has published editorials on tobacco control topics in the Canadian Journal of Anesthesia and the Canadain Medical Association Journ. He is an Assistant Professor at the University of Toronto and has recently retired from the position of Chief of Anesthesiology at The Scarborough Hospital.
Fiona Patten is a Member for Northern Metropolitan Region in the Victorian Parliament’s Legislative Council. Leader of the Reason Party, Fiona was first elected in 2014 and re-elected in 2018. Since being elected in 2014, Fiona has garnered respect from all sides of the political divide and has worked tirelessly to deliver legislative reforms that many thought impossible. Fiona is now working towards improving Victoria even further, and is pushing to legalise and regulate cannabis for adult use, continuing to implement electoral reform, religious accountability and greater separation of church and state, legalise sex work, and spent convictions legislation.
Tim Phillips is the Managing Director of Tamarind Intelligence, publisher of leading business intelligence services ECigIntelligence, CBD-Intel and TobaccoIntelligence. These independent market data and regulatory tracking and analysis services for the vape, CBD and tobacco-alternatives industries provide market leading insights into the sectors they cover for clients ranging from governments and academic institutions to multinational companies and professional service providers. Tim Phillips is a UK-qualified attorney, having worked at the European Commission, international law firm Herbert Smith, media companies BSkyB and AOL, and Betfair, where he worked in various legal and government relations roles as the company went through its IPO. He was also a partner in a New York venture capital-funded start-up in the diamond sector. Tim holds a postgraduate diploma in legal practice from the University of Law, London and a masters degree in geology from Oxford University. He has run for Tamarind Intelligence for the past 6 years.
Riccardo Polosa is the founder of the Center of Excellence for the acceleration of HArm Reduction (CoEHAR - University of Catania, Italy). Dr Polosa is Full Professor of Internal Medicine for the same University and Director of the Center for Smoking Prevention and Treatment at the University Hospital "Policlinico-V. Emanuele” of Catania. Dr. Polosa and the CoEHAR team of researchers conduct several high-profile clinical and behavioral research in the field of smoking-related diseases. According to a bibliometric analysis, Professor Polosa is considered the most productive scientist in the world in the field of electronic cigarette research.
Helen Redmond is an expert in substance use with over a decade of experience working with drug users and people with mental health problems. Her current focus is on helping smokers from vulnerable groups switch to e-cigarettes. At New York Harm Reduction Educators, Helen facilitates tobacco harm reduction/vaping groups. She is a senior editor at Filter and writes about vaping and creates short Op-Docs. Helen is adjunct faculty at the Silver School of Social Work at New York University.
Deborah Robson is a mental health nurse and researcher. Her current role involves the development, implementation and evaluation of tobacco dependence treatment initiatives for people with a mental health condition and/ or substance use disorder who smoke. She has developed online education courses and advanced skills training for treating tobacco dependence in mental health settings. Debbie is also involved in policy work e.g. she is a co-author of Public Health England commissioned reports about e-cigarettes and vaping.
Louise Ross managed the Leicester City (UK)Stop Smoking Service from 2004 to 2018. When vaping came along, she was initially sceptical, and was concerned about the risks and the problems it might bring. However, having met vapers at the first E-Cigarette Summit in London in 2013, she realised there was a huge potential benefit in embracing this new technology, and with her committed team rebranded themselves as the first ‘Ecig-friendly’ Stop Smoking Service. Since then she has celebrated the success of this initiative and vigorously challenges those who work against tobacco harm reduction.
Harry Shapiro, DrugWise Director, has worked in the drugs field for over 35 years, most recently as Director of Communications for DrugScope. He was DrugScope’s main media spokesperson, managing editor of Druglink and has written extensively on all aspects of drugs and drug-related issues combining this with lecturing, public speaking and advisory work for government. He remains the managing editor of DS Daily.
Professor Gerry Stimson is a public health social scientist, with over 40 years’ experience of research and advocacy. He was one of the founders of drugs harm reduction in the 1980s and helped develop and evaluate harm reduction in the UK as a response to HIV/AIDS. He has advised the UK Government, WHO, UNAIDS, UNODC, World Bank and numerous governments on issues relating to drugs, HIV infection and AIDS, and alcohol. He is an advocate for tobacco harm reduction as a key public health strategy for reducing smoking related harms. He has published over 220 scientific publications and several books. He is Honorary Professor at the London School of Hygiene and Tropical Medicine, Emeritus Professor at Imperial College London.
Dr. Sree T. Sucharitha, M.D, Professor, Department of Community Medicine, Tagore Medical College Hospital, Chennai, India holds Fellowship in HIV Medicine from CDC-I-Tech in partnership with Government of Tamil Nadu in India. She undertook web-based survey among ENDS Users in India and current projects include Tobacco Prevention, Control and Cessation Support Services for migrant construction site workers in Chennai, India. Scientific abstracts on ENDS-Indian Users were accepted for Poster presentation in CHI-Melbourne, 2019. Won Best paper awards for presentations at International Conference on Bioethics in Health Sciences (2020),Tamil Nadu Physical Education and Sports University (2019),Tamil Nadu Dr. MGR University (2018), IJRULA- Best Research Scientist-Environment Science (2018).
Dr Roberto A Sussman is a full time senior researcher and lecturer in physics at the National University of Mexico. He specializes in Theoretical Cosmology but has undertaken research and frequent peer reviewing for journals in other areas of Astrophysics. He is also the founder and Director of Pro-Vapeo Mexico, an association representing Mexican consumers of noncombustible nicotine products and is a member of INNCO. He is actively advocating for an appropriate regulation of Tobacco Harm Reduction products in Mexico. He directs and supervises the effort to spread scientific information on these products, as well as advising consumers on how to counter the misinformation and prejudice about them that is rampant throughout Latin America.
David Sweanor is an adjunct professor, Faculty of Law, and chair of the advisory board of the Centre for Health Law, Policy & Ethics at the University of Ottawa and has been actively involved in tobacco and health policy issues since the beginning of the 1980s. He has worked globally, and with numerous groups, including the International Union Against Cancer, World Health Organization, World Bank and the Pan American Health Organization and played a key role in achieving many global precedents in tobacco policy. He currently focuses much of his tobacco and nicotine related efforts on risk reduction strategies.
Dr. Mark Tyndall is a Professor at the UBC School of Population and Public Health. He is an infectious diseases specialist and epidemiologist with a focus on urban health, drug use and harm reduction. He is an author on over 250 peer-reviewed publications, and was co-lead investigator on the evaluation of Insite, North America’s first supervised injection site. His current work includes innovative solutions to prevent overdoses and the adverse health outcomes of drug use. Dr. Tyndall is a strong Canadian advocate for public health and has championed the scale-up of vaping as a response to reducing the harms associated with smoking.
Clarisse Virgino is a law student, aiming to specialize in international public policy and advocacy. A former local newspaper contributor, she started to smoke at a young age but has now been vaping for almost a decade and found it to be the best way to end cigarette smoking. She is engaged in educating smokers on alternative products as well as the benefits in switching to these alternatives. She is also pushing for the fair regulation of Electronic Nicotine Delivery System (ENDS) or E-Cigarettes in the Philippines. She is a member of the Coalition of Asia-Pacific Tobacco Harm Reduction Advocates (CAPHRA).
Dr Alex Wodak AM is a retired physician who is now President of the Australian Drug Law Reform Foundation. he works full time on drug law reform as a volunteer. Together with colleagues, he started the first needle syringe programme (1986) and the first medically supervised injecting centre (1999) in Australia when both were pre-legal. Dr Wodak was President of the International Harm Reduction Association (1996-2004). He has been interested in tobacco harm reduction since 1992 but only active in THR in recent years. Dr Wodak helped to start the National Drug and Alcohol Research Centre (1987).
Julie Woessner serves as President on INNCO’s Governing Board, thus representing the interests of thousands of nicotine consumers from all over the world. She is also the National Policy Director on the Board of Directors of CASAA (the Consumer Advocates for Smoke-free Alternatives Association). CASAA, a nonprofit U.S.-based public health and education nonprofit, advocates for people who consume, or might in the future consume, low-risk alternatives to cigarettes. CASAA engages in policy advocacy in the U.S. involving legislative and regulatory matters to protect access to low-risk products and mobilizes its 250,000+ members to do the same. Woessner holds a JD from Duke School of Law and was previously a practicing attorney.